Prospective Observation of the Incidence and Natural History of Monoclonal Gammopathy in Patients Undergoing Weight Reduction Surgery
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: Monoclonal Gammopathy | obesity
Age: Between 30 - 100 Years
Gender: Male or Female
Male or female patients 30 years or older planning to undergo weight reduction surgery or planning to enter into a physician monitored weight loss program
Patients must be obese, defined as a BMI greater than or equal to 30 as calculated by the formula: weight in pounds / height squared x 703 = BMI
To remain in the study for the follow-up phase, the baseline screening test must indicate that a patient has MGUS
No history of any malignancy except: adequately treated non-melanoma skin cancer, curatively treated in-situ cancer of the cervix, or other solid tumors curatively treated with no evidence of disease for greater than or equal to 5 years
No concurrent or planned participation in randomized trials of weight loss
A patient will be excluded from the follow-up phase if the baseline screening test indicates they do not have MGUS
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required